| Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease (NCT02232594) | Boehringer Ingelheim | 2000-01-01 |
| Efficacy of a Standardised Bilberry Extract in Improving the Night Vision of Healthy Volunteers (NCT02194361) | Boehringer Ingelheim | 1999-12-01 |
| Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer (NCT02204059) | Boehringer Ingelheim | 1999-12-01 |
| Micardis®. Observational Study in Patients With Essential Hypertension (NCT02200094) | Boehringer Ingelheim | 1999-12-01 |
| Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients (NCT02239835) | Boehringer Ingelheim | 1999-12-01 |
| Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type (NCT02249351) | Boehringer Ingelheim | 1999-12-01 |
| Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors (NCT02209701) | Boehringer Ingelheim | 1999-12-01 |
| Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen (NCT02191332) | Boehringer Ingelheim | 1999-12-01 |
| Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers (NCT02209714) | Boehringer Ingelheim | 1999-11-01 |
| Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets in Children (NCT02184325) | Boehringer Ingelheim | 1999-11-01 |
| Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects (NCT02170740) | Boehringer Ingelheim | 1999-11-01 |
| Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers (NCT02203487) | Boehringer Ingelheim | 1999-11-01 |
| Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy Recreational Sports People (NCT02182934) | Boehringer Ingelheim | 1999-11-01 |
| Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers (NCT02222961) | Boehringer Ingelheim | 1999-11-01 |
| Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers (NCT02264093) | Boehringer Ingelheim | 1999-11-01 |
| Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers (NCT02265653) | Boehringer Ingelheim | 1999-11-01 |
| Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects (NCT02209649) | Boehringer Ingelheim | 1999-10-01 |
| Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH) (NCT02175355) | Boehringer Ingelheim | 1999-10-01 |
| Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects (NCT02173678) | Boehringer Ingelheim | 1999-10-01 |
| Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers (NCT02266550) | Boehringer Ingelheim | 1999-10-01 |
| Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02249338) | Boehringer Ingelheim | 1999-10-01 |
| Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease (NCT02233907) | Boehringer Ingelheim | 1999-10-01 |
| Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects (NCT02187523) | Boehringer Ingelheim | 1999-10-01 |
| Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease (NCT02238158) | Boehringer Ingelheim | 1999-09-01 |
| Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease (NCT02236715) | Boehringer Ingelheim | 1999-09-01 |
| Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension (NCT02242370) | Boehringer Ingelheim | 1999-09-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Doses Oral BIRB 796 BS in Healthy Human Subjects (NCT02208856) | Boehringer Ingelheim | 1999-09-01 |
| Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers (NCT02278302) | Boehringer Ingelheim | 1999-08-01 |
| Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy Volunteers (NCT02182531) | Boehringer Ingelheim | 1999-08-01 |
| Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects (NCT02266511) | Boehringer Ingelheim | 1999-08-01 |
| Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects (NCT02273492) | Boehringer Ingelheim | 1999-08-01 |
| Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of BIBB 1464 MS in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food (NCT02229838) | Boehringer Ingelheim | 1999-07-01 |
| Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without Food (NCT02170922) | Boehringer Ingelheim | 1999-07-01 |
| The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma (NCT02249312) | Boehringer Ingelheim | 1999-07-01 |
| Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers (NCT02273479) | Boehringer Ingelheim | 1999-07-01 |
| Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male Volunteers (NCT02273414) | Boehringer Ingelheim | 1999-07-01 |
| Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02198326) | Boehringer Ingelheim | 1999-07-01 |
| Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172300) | Boehringer Ingelheim | 1999-06-01 |
| Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers (NCT02194296) | Boehringer Ingelheim | 1999-06-01 |
| Relative Bioavailability of Meloxicam 2 x 7.5 mg Tablets Compared to 15 mg Tablet and Dose Proportionality Over a Dose Range of 7.5 mg and 15 mg in Healthy Volunteers (NCT02276352) | Boehringer Ingelheim | 1999-06-01 |
| Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (NCT02176564) | Boehringer Ingelheim | 1999-06-01 |
| Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension (NCT02177487) | Boehringer Ingelheim | 1999-06-01 |
| Pharmacokinetic Study of Seresis® in the Skin in Healthy Young Female Volunteers (NCT02191852) | Boehringer Ingelheim | 1999-06-01 |
| Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers (NCT02170831) | Boehringer Ingelheim | 1999-05-01 |
| Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients (NCT02184286) | Boehringer Ingelheim | 1999-05-01 |
| Pharmacovigilance and Patient Compliance in Hypertensive Patients (NCT02200575) | Boehringer Ingelheim | 1999-05-01 |
| Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type (NCT02248116) | Boehringer Ingelheim | 1999-05-01 |
| Micardis® in Patients With Essential Hypertension (NCT02187705) | Boehringer Ingelheim | 1999-05-01 |
| Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL (NCT02268136) | Boehringer Ingelheim | 1999-04-01 |
| A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers (NCT02198313) | Boehringer Ingelheim | 1999-04-01 |
| Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients (NCT02184299) | Boehringer Ingelheim | 1999-04-01 |
| Influence of a High Fat Breakfast in the Pharmacokinetics of UH-AC62MU in Healthy Subjects (NCT02183103) | Boehringer Ingelheim | 1999-04-01 |
| Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee (NCT02183129) | Boehringer Ingelheim | 1999-04-01 |
| Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women (NCT02181933) | Boehringer Ingelheim | 1999-04-01 |
| Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults (NCT02182765) | Boehringer Ingelheim | 1999-04-01 |
| Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of BIBV 308 SE, Versus a Solution of BIBV 308 SE in Healthy Subjects (NCT02223013) | Boehringer Ingelheim | 1999-04-01 |
| Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease (NCT02172573) | Boehringer Ingelheim | 1999-04-01 |
| Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers (NCT02264080) | Boehringer Ingelheim | 1999-03-01 |
| Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck Cancer (NCT02204033) | Boehringer Ingelheim | 1999-03-01 |
| Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male Volunteers (NCT02199899) | Boehringer Ingelheim | 1999-03-01 |
| Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir (NCT02249130) | Boehringer Ingelheim | 1999-03-01 |
| Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy People (NCT02182882) | Boehringer Ingelheim | 1999-03-01 |
| Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD) (NCT02173691) | Boehringer Ingelheim | 1999-02-01 |
| Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects (NCT02264054) | Boehringer Ingelheim | 1999-02-01 |
| Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension (NCT02176499) | Boehringer Ingelheim | 1999-02-01 |
| Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172287) | Boehringer Ingelheim | 1999-02-01 |
| Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension (NCT02177435) | Boehringer Ingelheim | 1999-02-01 |
| Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine Headache (NCT02198339) | Boehringer Ingelheim | 1999-02-01 |
| Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects (NCT02222987) | Boehringer Ingelheim | 1999-02-01 |
| Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type (NCT02249403) | Boehringer Ingelheim | 1999-01-01 |
| Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects (NCT02265289) | Boehringer Ingelheim | 1999-01-01 |
| Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension (NCT02176850) | Boehringer Ingelheim | 1999-01-01 |
| Single Increasing Dose Tolerance Study in Healthy Male Volunteers of BIIR 561 CL (NCT02222974) | Boehringer Ingelheim | 1999-01-01 |
| Dose Extension Study of BIIX 1 XX in Healthy Young Male Volunteers (NCT02198287) | Boehringer Ingelheim | 1999-01-01 |
| Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease (NCT02231424) | Boehringer Ingelheim | 1999-01-01 |
| Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients (NCT02238314) | Boehringer Ingelheim | 1999-01-01 |
| Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease (NCT02238145) | Boehringer Ingelheim | 1999-01-01 |
| Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine (NCT02184091) | Boehringer Ingelheim | 1999-01-01 |
| Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease (NCT02231437) | Boehringer Ingelheim | 1999-01-01 |
| Safety and Tolerability of Pharmaton Capsules in Healthy Volunteers (NCT02181959) | Boehringer Ingelheim | 1998-12-01 |
| Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease (NCT02238132) | Boehringer Ingelheim | 1998-12-01 |
| Long-term Administration Study of SND 919 Tablets in Parkinson's Disease (NCT00274131) | Boehringer Ingelheim | 1998-12-01 |
| Efficacy and Safety of Metamizole Versus Placebo as Antithermic Therapy in the Acute Phase of Ischemic Stroke (NCT02184260) | Boehringer Ingelheim | 1998-12-01 |
| Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints (NCT02184364) | Boehringer Ingelheim | 1998-11-01 |
| Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers (NCT02260063) | Boehringer Ingelheim | 1998-11-01 |
| Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers (NCT02183259) | Boehringer Ingelheim | 1998-11-01 |
| Efficacy and Tolerability of a Bilberry Extract in Volunteers With Impaired Twilight and Night Vision (NCT02194127) | Boehringer Ingelheim | 1998-11-01 |
| Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers (NCT02170116) | Boehringer Ingelheim | 1998-11-01 |
| Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects (NCT02183090) | Boehringer Ingelheim | 1998-11-01 |
| The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers (NCT02264145) | Boehringer Ingelheim | 1998-11-01 |
| Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients (NCT02177357) | Boehringer Ingelheim | 1998-11-01 |
| Use of Synvisc® in Knee Osteoarthritis - Survey on Practice (NCT02195544) | Boehringer Ingelheim | 1998-10-01 |
| Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis (NCT02197026) | Boehringer Ingelheim | 1998-10-01 |
| Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy (NCT02181335) | Boehringer Ingelheim | 1998-10-01 |
| Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects (NCT02203500) | Boehringer Ingelheim | 1998-10-01 |
| Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease (NCT02248220) | Boehringer Ingelheim | 1998-10-01 |
| Safety of Terbogrel in Patients With Primary Pulmonary Hypertension (NCT02223494) | Boehringer Ingelheim | 1998-10-01 |
| Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02182583) | Boehringer Ingelheim | 1998-10-01 |
| Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache (NCT02183220) | Boehringer Ingelheim | 1998-10-01 |
| Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers (NCT02177305) | Boehringer Ingelheim | 1998-10-01 |